Oligomaker ApS
Private limited companyCVR 12783388FrederiksbergActive
Oligomaker ApS is a private limited company, based in Frederiksberg, active in manufacture of basic pharmaceutical products, founded in 1989. After a loss in 2025, the company made a profit of DKK 638k in 2026. Equity grew to DKK 2.5m in 2026.
Key figures · financial year 2026
What has changed
calculated from recorded figures and datesFinancials: 2026 against 2025
- Net profit went from a loss of DKK 1.4m to a profit of DKK 638k (2025 → 2026).
- Equity rose 34% (2025 → 2026), to DKK 2.5m.
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2021–2026 · amounts in DKK thousandEquity and net profit
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 2,556 | 3,610 | 3,278 | 2,799 | −145 | 1,547 | +1,170.3% |
| Operating profit (EBIT) | – | – | – | – | – | 655 | – |
| Profit before tax | 2,504 | 3,530 | 2,359 | 1,669 | −1,383 | 638 | +146.1% |
| Net profit | 1,952 | 2,749 | 1,837 | 1,300 | −1,383 | 638 | +146.1% |
| Total assets | 4,186 | 4,308 | 3,752 | 4,564 | 2,103 | 2,612 | +24.2% |
| Equity | 2,489 | 2,939 | 2,476 | 2,276 | 1,892 | 2,531 | +33.7% |
| Liabilities | 1,697 | 1,370 | 1,276 | 2,288 | 210 | 81 | −61.3% |
| Cash and cash equivalents | 369 | 951 | 1,253 | 2,036 | 605 | 456 | −24.6% |
| Average number of employees | 1 | 1 | 1 | 2 | 2 | 2 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025, 2026: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2026 | 01/07/2025 – 30/06/2026 | 30/09/2026 | The company | PDF not statedXBRL |
| 2025 | 01/07/2024 – 30/06/2025 | 28/10/2025 | The company | PDF not statedXBRL |
| 2024 | 01/07/2023 – 30/06/2024 | 23/10/2024 | The company | PDFXBRL |
| 2023 | 01/07/2022 – 30/06/2023 | 20/10/2023 | The company | PDFXBRL |
| 2022 | 01/07/2021 – 30/06/2022 | 22/09/2022 | The company | PDFXBRL |
| 2021 | 01/07/2020 – 30/06/2021 | 20/09/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
14 companies in the databaseComparison with the other companies in manufacture of basic pharmaceutical products based on the latest financial year.
Industry median: gross profit DKK 13.9m, net profit DKK 80,789, equity DKK 10.1m, 19 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 36,276of 69,742 Better than 48% | No. 21,375of 69,964 Better than 69% |
| Companies that are at least 30 years old10,276 companies in the comparison | No. 7,694of 10,152 Better than 24% | No. 7,510of 10,275 Better than 27% |
| All companies of type ApS66,508 companies in the comparison | No. 35,036of 66,379 Better than 47% | No. 17,729of 66,505 Better than 73% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of basic pharmaceutical products- Oligomaker ApSDKK 1.5m
- Xellia Pharmaceuticals ApSDKK 314.9m
- Glycom Manufacturing A/SDKK 226.3m
- Oligomaker ApSDKK 638k
- Xellia Pharmaceuticals ApSDKK 213.7m
- Glycom Manufacturing A/SDKK 69.2m
- Oligomaker ApSDKK 2.5m
- Xellia Pharmaceuticals ApSDKK 404.6m
- Glycom Manufacturing A/SDKK 577.7m
- Oligomaker ApS2
- Xellia Pharmaceuticals ApS458
- Glycom Manufacturing A/S116
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- K.j. Ross-petersen ApS100%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Karl Jakob Ross-Petersen | Director | 12/07/2006 |
- Founders
- Asx 9667 ApS
Former management (5)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Steen Schierbeck | Director | 01/01/1989 | 05/09/1989 |
| Per Høpfner | Director | 01/01/1989 | 09/04/1996 |
| Lone Ross Nylandsted | Board member | 01/01/1989 | 11/01/2001 |
| Jakob Riemann Ross-Petersen | Board member | 01/01/1989 | 11/01/2001 |
| Jakob Riemann Ross-Petersen | Director | 01/01/1989 | 12/07/2006 |
Signing rule: Selskabet tegnes af en direktør alene.
Address and production units
1 active production unitsKong Georgs Vej 12B
2000 Frederiksberg
Frederiksberg Municipality · Postcode 2000
Other companies at the address (2)
- Tag Copenhagen A/SResearch and experimental development on natural sciences and engineering
- Edu Games ApSOther education n.e.c.
| Production unit | Address | Employees | P number |
|---|---|---|---|
| OLIGOMAKER ApS | Kong Georgs Vej 12B, 2000 Frederiksberg | 2 | 1003719994 |
Purpose
Selskabets formål er at drive virksomhed med handel, forskning og produktion og udføre andre i forbindelse hermed stående erhvervsmæssige opgaver.
The purpose is quoted from the register in Danish.
Changes year by year
29 registered events20261 changeaccounts 1
- AccountsAnnual report for 2026 published
20251 changeaccounts 1
- AccountsAnnual report for 2025 published
20241 changeaccounts 1
- AccountsAnnual report for 2024 published
20231 changeaccounts 1
- AccountsAnnual report for 2023 published
20221 changeaccounts 1
- AccountsAnnual report for 2022 published
20211 changeaccounts 1
- AccountsAnnual report for 2021 published
20181 changeaddress 1
- AddressMoved to Kong Georgs Vej 12B, 2000 Frederiksberg
20121 changeaddress 1
- AddressMoved to Kong Georgs Vej 12, 2000 Frederiksberg
20082 changesname 1 · ownership 1
- NameName changed from T-A-G-C ApS to OLIGOMAKER ApS
- OwnershipK.J. ROSS-PETERSEN ApS registered as owner (100%)
20062 changesmanagement 2
- ManagementKarl Jakob Ross-Petersen appointed director
- ManagementJakob Riemann Ross-Petersen stepped down as director
20031 changeaddress 1
- AddressMoved to Fruebjergvej 3, 2100 København Ø
20012 changesmanagement 2
- ManagementLone Ross Nylandsted stepped down as board member
- ManagementJakob Riemann Ross-Petersen stepped down as board member
19981 changename 1
- NameName changed from T-A-G-COPENHAGEN ApS to T-A-G-C ApS
19971 changecapital 1
- CapitalShare capital changed from 80,000 DKK to 125,000 DKK
19962 changesname 1 · management 1
- NameName changed from K/S AF 1.APRIL 1989 ApS to T-A-G-COPENHAGEN ApS
- ManagementPer Høpfner stepped down as director
198910 changesname 1 · management 6 · founded 1 · ownership 2
- NameName changed from ASX 14792 ApS to K/S AF 1.APRIL 1989 ApS
- ManagementSteen Schierbeck stepped down as director
- FoundedRegistered as ASX 14792 ApS
- ManagementSteen Schierbeck appointed director
- ManagementPer Høpfner appointed director
- ManagementLone Ross Nylandsted appointed board member
- ManagementJakob Riemann Ross-Petersen appointed board member
- ManagementJakob Riemann Ross-Petersen appointed director
- OwnershipKarl Jakob Ross-Petersen registered as owner (100%)
- OwnershipKarl Jakob Ross-Petersen is no longer registered as owner
Related companies
Same people in management
- Danfoss Power Solutions ApSvia Steen Schierbeck
- Vivaldi Gruppen A/Svia Steen Schierbeck
- Milestone Systems A/Svia Steen Schierbeck
- INDITEX Danmark A/Svia Steen Schierbeck
- Dan-foam ApSvia Steen Schierbeck
- Attendo A/Svia Steen Schierbeck
Largest in the industry
- Xellia Pharmaceuticals ApSDKK 314.9m
- Glycom Manufacturing A/SDKK 226.3m
- Biofac A/SDKK 73.6m
- Zpd A/SDKK 52.7m
- Danipharm A/SDKK 37.6m
- Pharma Medico ApSDKK 32.3m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.